Literature DB >> 29035919

Attenuation of compulsive-like behavior by fluvoxamine in a non-induced mouse model of obsessive-compulsive disorder.

Swarup Mitra1,2, Abel Bult-Ito3.   

Abstract

The current study evaluated the role of strain and compulsive trait differences in response to fluvoxamine, a common obsessive-compulsive disorder (OCD) drug, in two different mouse strains (BIG1 and BIG2) with a spontaneous compulsive-like phenotype. For compulsive-like nest-building behavior, dose-dependent attenuation of nesting by fluvoxamine was observed for the BIG1 compulsive-like strain during the first hour after administration. No significant differences were found for the BIG2 strain during the first hour, although a dose-dependent trend similar to that in the BIG1 strain was observed. Fluvoxamine dose dependently decreased the number of marbles buried in both strains 1 h after administration. For anxiety-like behaviors in the open field, no significant drug effects were found for the latency to leave the center and the number of line crossings. Significant strain differences were observed, with the BIG2 strain showing higher anxiety-like behaviors and reduced locomotor activity compared with the BIG1 strain. Consequently, this study adds predictive validity to our mouse model of OCD, whereas the anxiety-like differences between the strains add heterogeneity to our mouse model, similar to the heterogeneity observed in OCD.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29035919      PMCID: PMC5899065          DOI: 10.1097/FBP.0000000000000348

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  67 in total

1.  Anxiety and OCD - the chicken or the egg?

Authors:  David Nutt; Andrea Malizia
Journal:  J Psychopharmacol       Date:  2006-11       Impact factor: 4.153

2.  A screen of SLC1A1 for OCD-related alleles.

Authors:  Y Wang; A Adamczyk; Y Y Shugart; J F Samuels; M A Grados; B D Greenberg; J A Knowles; J T McCracken; S L Rauch; D L Murphy; S A Rasmussen; B Cullen; A Pinto; A J Fyer; J Piacentini; D L Pauls; O J Bienvenu; M Riddle; K Y Liang; D Valle; T Wang; G Nestadt
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-03-05       Impact factor: 3.568

3.  Effect of YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT 2A receptor antagonistic activity, on a marble-burying behavior test as an obsessive-compulsive disorder model.

Authors:  Hiromi Takeuchi; Shin-ichi Yatsugi; Tokio Yamaguchi
Journal:  Jpn J Pharmacol       Date:  2002-10

Review 4.  Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions.

Authors:  W K Goodman; H Ward; A Kablinger; T Murphy
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

Review 5.  The inheritance of obsessive-compulsive disorder.

Authors:  D L Pauls; J P Alsobrook
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  1999-07

6.  Marked inbred mouse strain difference in the expression of quinpirole induced compulsive like behavior based on behavioral pattern analysis.

Authors:  Ria de Haas; Amir Seddik; Hugo Oppelaar; Herman G M Westenberg; Martien J H Kas
Journal:  Eur Neuropsychopharmacol       Date:  2012-02-11       Impact factor: 4.600

Review 7.  The neurocircuitry of fear, stress, and anxiety disorders.

Authors:  Lisa M Shin; Israel Liberzon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

8.  Functional magnetic resonance imaging study of regional brain activation during implicit sequence learning in obsessive-compulsive disorder.

Authors:  Scott L Rauch; Michelle M Wedig; Christopher I Wright; Brian Martis; Katherine G McMullin; Lisa M Shin; Paul A Cannistraro; Sabine Wilhelm
Journal:  Biol Psychiatry       Date:  2006-02-21       Impact factor: 13.382

9.  SERT Ileu425Val in autism, Asperger syndrome and obsessive-compulsive disorder.

Authors:  Jens R Wendland; Theresa B DeGuzman; Francis McMahon; Gary Rudnick; Sevilla D Detera-Wadleigh; Dennis L Murphy
Journal:  Psychiatr Genet       Date:  2008-02       Impact factor: 2.458

10.  5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice.

Authors:  Y Ichimaru; T Egawa; A Sawa
Journal:  Jpn J Pharmacol       Date:  1995-05
View more
  1 in total

Review 1.  Bidirectional Behavioral Selection in Mice: A Novel Pre-clinical Approach to Examining Compulsivity.

Authors:  Swarup Mitra; Abel Bult-Ito
Journal:  Front Psychiatry       Date:  2021-09-08       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.